scholarly article | Q13442814 |
P50 | author | Jih-Hwa Guh | Q40601635 |
Yao-Ting Huang | Q56154120 | ||
Che-Ming Teng | Q56996745 | ||
P2093 | author name string | Sheng-Chu Kuo | |
Shiow-Lin Pan | |||
Ya-Ling Chang | |||
Fang-Yu Lee | |||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | prostate cancer | Q181257 |
P304 | page(s) | 1628-1635 | |
P577 | publication date | 2005-10-01 | |
P1433 | published in | Molecular Cancer Therapeutics | Q2363144 |
P1476 | title | YC-1 suppresses constitutive nuclear factor-kappaB activation and induces apoptosis in human prostate cancer cells | |
P478 | volume | 4 |
Q84985820 | Bp5250 inhibits vascular endothelial growth factor-induced angiogenesis and HIF-1α expression on endothelial cells |
Q39503219 | Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell lines. |
Q38772682 | Cytotoxic activity of the novel heterocyclic compound G-11 is primarily mediated through intrinsic apoptotic pathway. |
Q33601510 | Effects of TLR agonists on the hypoxia-regulated transcription factor HIF-1alpha and dendritic cell maturation under normoxic conditions |
Q39790544 | Inhibition of constitutive and cxc-chemokine-induced NF-kappaB activity potentiates ansamycin-based HSP90-inhibitor cytotoxicity in castrate-resistant prostate cancer cells |
Q39415018 | KMUP-1 inhibits H441 lung epithelial cell growth, migration and proinflammation via increased NO/CGMP and inhibited RHO kinase/VEGF signaling pathways |
Q54405180 | Mutant p53 subverts p63 control over KLF4 expression in keratinocytes. |
Q42377201 | Pharmacological HIF-inhibition attenuates postoperative adhesion formation |
Q33587139 | Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage |
Q35210888 | Retracted: Nuclear Factor Kappa-B Signaling Is Integral to Ocular Neovascularization in Ischemia-Independent Microenvironment |
Q34637708 | Retracted: The Nexus between VEGF and NFκB Orchestrates a Hypoxia-Independent Neovasculogenesis |
Q36642960 | The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development |
Q37767875 | The ubiquitin-proteasome system in prostate cancer and its transition to castration resistance |
Q50104130 | Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies |
Q36052832 | YC-1 attenuates LPS-induced proinflammatory responses and activation of nuclear factor-kappaB in microglia. |
Q37493227 | YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma |
Q37183795 | YC-1 exerts inhibitory effects on MDA-MB-468 breast cancer cells by targeting EGFR in vitro and in vivo under normoxic condition |
Q33821469 | YC-1 induces G0/G1 phase arrest and mitochondria-dependent apoptosis in cisplatin-resistant human oral cancer CAR cells |
Q36964934 | YC-1 induces apoptosis of human renal carcinoma A498 cells in vitro and in vivo through activation of the JNK pathway |
Q40184763 | YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia |
Q42810913 | YC-1 rescues cancer cachexia by affecting lipolysis and adipogenesis. |
Q39672848 | YC-1, a novel potential anticancer agent, inhibit multidrug-resistant protein via cGMP-dependent pathway. |
Q64937707 | YC‑1 reduces inflammatory responses by inhibiting nuclear factor‑κB translocation in mice subjected to transient focal cerebral ischemia. |
Search more.